Tuesday, April 14, 2026 2:55 AM ET
37 minutes ago
Revolution Medicines says its pancreatic cancer drug succeeds in late-stage trial37 minutes ago
A mom tech entrepreneur building AI advocate for rare-disease families like hers18 hours ago
Trump policies, China's biotech boom are ending Europe's pharma powerhouse era3 days ago
Former senator shines spotlight on a possible breakthrough for pancreatic cancer3 days ago
CNBC Cures: A doctor dad on how raising child with Angelman syndrome changed him3 days ago
Novo Nordisk's Wegovy pill launch draws a new wave of patients into GLP-1s4 days ago
Trump admin finalizes better-than-feared Medicare Advantage payment rate6 days ago
FDA declines to issue specific guidance on health programs' foreign drug imports7 days ago
Trump administration sets up to 100% tariffs on some imported drugs7 days ago
Novo Nordisk says Wegovy pill outperforms Lilly's oral GLP-1 in cross-trial comparison11 days ago
Eli Lilly opposes White House push to codify most favored nation drug pricing11 days ago
FDA approves Eli Lilly's GLP-1 pill, opening next phase for weight loss drugs12 days ago
Stocks soar on hopes of war resolution — plus, Lilly takes a swing in sleep disorders12 days ago
Lilly to spend up to $7.8 billion to acquire Centessa, sleep disorder drugmaker13 days ago
Novo Nordisk launches Wegovy subscriptions as it tries to catch up with Eli Lilly13 days ago
Eli Lilly reaches deal to bring AI-developed drugs to global market13 days ago
AstraZeneca stock jumps after surprise lung disease trial win15 days ago
Pfizer to seek approval for Lyme disease vaccine candidate despite trial miss17 days ago
Danone to buy protein shake maker Huel as health nutrition craze drives demand shift21 days ago
The price of menstrual products is skyrocketing from inflation, tariffs22 days ago
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up23 days ago
How CNBC Cures is bringing rare disease stories to a national audience24 days ago
FDA approves higher-dose version of Novo Nordisk's obesity drug Wegovy24 days ago
9% of ACA health-care plan enrollees uninsured after enhanced subsidies expire: Poll25 days ago
Eli Lilly's obesity drug retatrutide clears first late-stage diabetes trial25 days ago
Stopping GLP-1s raises risk of heart attack, stroke and death, study says25 days ago
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi26 days ago
Eli Lilly shares slide after a bearish Wall Street analyst call — here's our view27 days ago
Trump says White House chief of staff Susie Wiles has breast cancer27 days ago
Vertex passes key test in quest to treat kidney diseases1 month ago
FDA approves leucovorin as first drug for rare genetic disorder1 month ago